Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer

The Barcelona magnetic resonance imaging (MRI)-based risk calculator (BCN MRI-RC) exhibited, in the analysed population, better behaviour than the Rotterdam-MRI risk calculator to improve candidate selection for prostate biopsy for the early detection of clinically significant prostate cancer. We note the importance of the discrimination, net benefit, and clinical utility analysis regarding Prostate Imaging Reporting and Data System (PI-RADS) categories. We summarise that both risk calculators were helpful in men with PI-RADS 3, only the BCN MRI-RC in those with PI-RADS 4, and none of these in men with negative MRI and PI-RADS 5.